Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
22nd Annual Women’s Health Annual Visit (WHAV)
November 13, 2026
Pasadena, California
Turning Flares Into Function: Flag Uncontrolled Disease
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
The 2-Point Signal: Apply ≥2-Point Rule
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Minimal By Design: Define MSE Endpoints
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
December 04, 2026
New York, New York
FcRn: Same Class, Different Paths—Spot Agent Differentiators
When to Begin FcRn: Initiation Criteria, Key Evidence
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Escalate With Intention: Stepwise, Target-Anchored Moves
The IgG Clock: Redose Using IgG Kinetics
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
The Alloimmune Disorders of Pregnancy
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Linda Bradley, MD
Melissa Simon, MD
Casey Joe Hinds
Pre- and Postoperative Use of GnRH Antagonists
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Samantha Denäe
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Alloimmune Neutropenia of the Fetus and Newborn
Masja de Haas, MD, PhD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.